Hyalobarrier Gel, Hyalobarrier Gel Endo Israeli - Kiebrania - Ministry of Health

hyalobarrier gel, hyalobarrier gel endo

easy-care ltd (of tec-o-pharm group) - רופא - for prevention or reduction of post surgical adhesion formation in the abdomino-pelvic area, for use in open surgery procedures. for use in laparoscopic and hysteroscopic surgical procedures.

HYALOBARRIER GEL, HYALOBARRIER ENDO GEL Israeli - Kiebrania - Ministry of Health

hyalobarrier gel, hyalobarrier endo gel

easy-care ltd (of tec-o-pharm group) - רופא - for prevention or reduction of post surgical adhesion formation in the abdomino-pelvic area, for use in open surgery procedures. for use in laparoscopic and hysteroscopic surgical procedure

פרמיקסון 160 מג Israeli - Kiebrania - Ministry of Health

פרמיקסון 160 מג

padagis israel agencies ltd, israel - lipidosterolic extract of serenoa repens - קפסולות - lipidosterolic extract of serenoa repens 160 mg

אווסטין Israeli - Kiebrania - Ministry of Health

אווסטין

roche pharmaceuticals (israel) ltd - bevacizumab - תרכיז להכנת תמיסה לאינפוזיה - bevacizumab 25 mg/ml - bevacizumab - bevacizumab - avastin in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum.avastin in addition to platinum - based chemotherapy is indicated for first - line treatment of patients with unresectable advanced metastatic or recurrent non- small cell lung cancer other than predominantly squamous cell histology. avastin in combination with interferon alfa-2a is indicated for first line treatment of patients with advanced and /or metastatic renal cell cancer. avastin in combination with paclitaxel is indicated for first-line treatment of patients with metastatic breast cancer.avastin as asingle agent, is indicated for the treatment of glioblastoma in patients with progressive disease following prior therapy.avastin, in combination with carboplatin and paclitaxel, is indicated for the front-line treatment of advanced (figo stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who are at hig

זלבוראף Israeli - Kiebrania - Ministry of Health

זלבוראף

roche pharmaceuticals (israel) ltd - vemurafenib - טבליות מצופות פילם - vemurafenib 240 mg - vemurafenib - vemurafenib - zelboraf is indicated for the treatment of brafv600 mutation-positive unresectable or metastatic melanoma.

טייקרב Israeli - Kiebrania - Ministry of Health

טייקרב

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

סטאלבו   10025200 מג Israeli - Kiebrania - Ministry of Health

סטאלבו 10025200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

סטאלבו   5012.5200 מג Israeli - Kiebrania - Ministry of Health

סטאלבו 5012.5200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Accessories for operating rooms Israeli - Kiebrania - Ministry of Health

accessories for operating rooms

אורטה מדיקל בע"מ - רופא - מיועד לבתי חולים,מרפאות עם חדרי ניתוח

Accessories for operating rooms Israeli - Kiebrania - Ministry of Health

accessories for operating rooms

אורטה מדיקל בע"מ - רופא - מיועד לבתי חולים,מרפאות עם חדרי ניתוח